Open AccessOutcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment – A quasi-randomized retrospective study
Author(s) -
Debdulal Chakraborty,
Aniruddha Maiti,
Aditya Kelkar,
Sabyasachi Sengupta,
Sangeeta Roy,
Mounika Bolisetty,
Akshay Kothari,
Jaydeep Majumder
Publication year - 2021
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_1264_21
Subject(s) - medicine , vitrectomy , ophthalmology , bevacizumab , visual acuity , retrospective cohort study , retinal detachment , diabetic retinopathy , retinal , surgery , chemotherapy , diabetes mellitus , endocrinology
To assess whether preoperative bevacizumab (BVZ) in treatment-naïve eyes with proliferative diabetic retinopathy (PDR) and vitreous hemorrhage (VH) without tractional retinal detachment (TRD) leads to lesser macular edema and better visual outcome compared to eyes that do not receive BVZ.